Unichem Laboratories is currently trading at Rs. 137.35, up by 9.90 points or 7.77% from its previous closing of Rs. 127.45 on the BSE.
The scrip opened at Rs. 136.70 and has touched a high and low of Rs. 139.70 and Rs. 134.35 respectively.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 200.60 on 24-May-2019 and a 52 week low of Rs. 75.10 on 24-Mar-2020.
Last one week high and low of the scrip stood at Rs. 140.05 and Rs. 127.00 respectively. The current market cap of the company is Rs. 897.32 crore.
The promoters holding in the company stood at 50.62%, while Institutions and Non-Institutions held 11.26% and 38.12% respectively.
Unichem Laboratories has received the Establishment Inspection Report (EIR) from United Stated Food and Drug Administration (USFDA) on May 13, 2020 for its Active Pharmaceutical Ingredients (APIs) facility at Roha. The USFDA conducted the inspection of its Roha facility from February 17, 2020 to February 21, 2020.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.
